Abstract
We report on the impact of a set of variations located in the HSP-70 (heat shock protein 70) and TAAR6 (trace amine associated receptors 6 gene) in a sample of bipolar patients. Holding a diagnosis of BPD was the first outcome measure. Response to pharmacotreatment in bipolar patients was the secondary outcome measure. One hundred seventy-one bipolar patients and 288 controls were enrolled for the study. Patients were administered HAM-D, YMRS and CGI at baseline and discharge by independent psychiatrists blind to genotypes. As a result, homozygosis at rs2075799 (HSP-70) was found to be more represented in controls than in cases (p = 0.000009). The investigated variations did not show impact on treatment outcome. This study provides preliminary evidence that HSP-70 may play a role in the disrupted mechanisms that lead to BPD. Further confirmatory analyses in this direction are mandatory.
| Original language | English |
|---|---|
| Pages (from-to) | 257-261 |
| Number of pages | 5 |
| Journal | Neuroscience Letters |
| Volume | 465 |
| Issue number | 3 |
| DOIs | |
| State | Published - 20 Nov 2009 |
Bibliographical note
Funding Information:This work was supported by a financial support of the Catholic Medical Center Research Foundation made in the program year of 2009 and by a grant from the Medical Research Center, Korea Science and Engineering Foundation, Republic of Korea ( R13-2002-005-04001-0 ).
Keywords
- Association
- Bipolar disorder
- Gene
- Heat shock proteins
- Trace amine associated receptor